SCHEMBL7241348

SCHEMBL7241348

CC(=O)Nc1ccc(C2=C3C=CC(=N3)C(c3cnc4ccccc4c3)=C3C=CC(=N3)C(c3cnc4ccccc4c3)=C3C=CC(=N3)C(c3cnc4ccccc4c3)=C3C=CC2=N3)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.45
▸ KDM4E B2RXH2 6/20 0.45
▸ MAPT P10636 5/20 0.45
▸ MEN1 O00255 5/20 0.45
▸ NPC1 O15118 5/20 0.45
▸ RAB9A P51151 5/20 0.45
▸ PABPC1 P11940 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ POLB P06746 2/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ HPGD P15428 3/20 0.44
▸ RXFP1 Q9HBX9 2/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ MAPK10 P53779 1/20 0.44
▸ CNR1 P21554 1/20 0.44
▸ CNR2 P34972 1/20 0.44
▸ MTOR P42345 1/20 0.44
▸ TP53 P04637 1/20 0.43
▸ STAT1 P42224 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26613449 0.82 MAPK10 (0.57) KMT2AKDM4EMAPTMEN1NPC1
SCHEMBL10568742 0.82 SMN1; SMN2 (0.56) KMT2AKDM4EMAPTMEN1NPC1
SCHEMBL7246191 0.79 PIK3CD (0.45) KMT2AKDM4EMAPTMEN1NPC1
SCHEMBL7241026 0.76 TSHR (0.49) KMT2AKDM4EMAPTMEN1NPC1
SCHEMBL7239834 0.76 NPC1 (0.52) KMT2AKDM4EMAPTMEN1NPC1
SCHEMBL7265162 0.74 SMN1; SMN2 (0.46) KMT2AKDM4EMAPTMEN1SMN1; SMN2
SCHEMBL879571 0.73 KDM4E (0.70) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7241342 0.72 TOP1 (0.44) KMT2AKDM4EMAPTMEN1NPC1
SCHEMBL8865142 0.72 NPC1 (0.50) KMT2AKDM4EMAPTMEN1NPC1
Hydrochloric Acid SCHEMBL8203837 0.72 CYP2A6 (0.62) KDM4EMAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030105130-A1 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-06-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105130-A1 Thiaporphyrin, selenaporphyrin, and carotenoid porphyrin compounds as c-myc and telomerase inhibitors MYCBP, MYC, TERF2IP KMT2A 2903/4885KDM4E 3753/4885MAPT 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback